Alacrita Consulting

Alacrita is a pharma and biotech consulting firm established in 2009 and headquartered in the United States. The company prides itself in its industry-leading consultants who possess the full range of specialist expertise required to develop and commercialize drug products. Alacrita's value proposition lies in the first-hand experience of its subject matter experts, who have dedicated their careers to discovering, developing, manufacturing, and commercializing drug products. The core team at Alacrita leverages a purpose-built network of over 250 experts, who are seamlessly integrated into project teams when specialist expertise is required. This unique approach enables the company to provide clients with precisely relevant support on a variety of research and development and business issues, all while maintaining the speed and flexibility expected of a professional life science consulting firm. Alacrita offers substantial expertise and experience in various areas, including clinical development, CMC & supply chain, interim chief medical officer support, preclinical strategy and execution, regulatory affairs, research and IP evaluation, business plans and fundraising support, opportunity mapping, new product planning, launch planning, asset scouting, due diligence, licensing, partnering and dealmaking, as well as pharma and biotech valuations. Overall, Alacrita stands ready to support clients through every stage of the pharmaceutical product development process, leveraging its scientific, clinical, and commercial expertise to maximize value at each stage. For those seeking tailored and experienced consulting services in the pharmaceutical and biotech sectors, Alacrita presents itself as a compelling option to explore. To learn more, visit www.alacrita.com.